BioCardia Inc. – Filings and Transcripts

NASDAQ: BCDA
Share price (10/20/26): $1.04
Market cap (10/20/26): $15.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2 2025 – amended

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement with pricing info

Initial registration of new securities – amended

Ownership Filter

News Filter

Announces FDA Acceptance of De Novo Pre-Submission Package for HelixTM Catheter Marketing Clearance FDA Substantive Review and Meeting Expected This Quarter

Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting

Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Notice of effectiveness

Notice of effectiveness